Literature DB >> 8893386

The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients.

A Pietinalho1, M Ohmichi, Y Hiraga, A B Löfroos, O Selroos.   

Abstract

We compared the clinical picture of sarcoidosis in patients diagnosed at Mjölbolsta hospital in Finland in 1955-1987 with those diagnosed in Sapporo in 1964-1988. The female:male ratios showed a slight female predominance. The mean age (SD) at diagnosis was 41.5 (13.0) years at Mjölbolsta and 30.0 (15.4) years in Sapporo. In both series, half of the patients had been detected at mass x-ray surveys. The presenting symptoms varied considerably among the symptomatic patients. At Mjölbolsta hospital, 189 patients (33%) had cough, 21% fever, 21% general malaise, 18% dyspnoea, 18% erythema nodosum, 16% joint pain and only 27 patients (5%) had eye symptoms. In Sapporo, 245 patients (41%) had eye symptoms, 18 (4%) had enlarged peripheral lymph nodes, 14 (3%) had cough, 10 (2%) had fever. Erythema nodosum did not occur as a presenting symptom in Sapporo. The chest radiographs showed bilateral hilar lymphadenopathy (BHL, stage I) in 48% of the Mjölbolsta patients and in 57% of the Sapporo patients. Stage II lesions were seen in 39% and 20%, and stage III lesions in 12% and 5% respectively. Only 1% had a normal chest radiograph at Mjölbolsta hospital as compared with 18% in Sapporo. The Sapporo patients were more obstructive but the proportion of smokers was also higher. No difference in diffusion capacity was seen.

Entities:  

Mesh:

Year:  1996        PMID: 8893386     DOI: 10.1007/bf00389839

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  14 in total

Review 1.  Genetic interstitial lung disease.

Authors:  Megan Stuebner Devine; Christine Kim Garcia
Journal:  Clin Chest Med       Date:  2011-12-06       Impact factor: 2.878

Review 2.  A concise review of pulmonary sarcoidosis.

Authors:  Robert P Baughman; Daniel A Culver; Marc A Judson
Journal:  Am J Respir Crit Care Med       Date:  2010-10-29       Impact factor: 21.405

3.  The six-minute walk test in patients with pulmonary sarcoidosis.

Authors:  Esam H Alhamad
Journal:  Ann Thorac Med       Date:  2009-04       Impact factor: 2.219

Review 4.  Obstructive sarcoidosis.

Authors:  Petey Laohaburanakit; Andrew Chan
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

Review 5.  Clinical and immunologic components of sarcoidosis.

Authors:  Andrea T Borchers; Calvin So; Stanley M Naguwa; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

6.  Sarcoidosis Diagnostic Score: A Systematic Evaluation to Enhance the Diagnosis of Sarcoidosis.

Authors:  Alexandra N Bickett; Elyse E Lower; Robert P Baughman
Journal:  Chest       Date:  2018-05-17       Impact factor: 9.410

Review 7.  Management of neurosarcoidosis: a clinical challenge.

Authors:  Mareye Voortman; Marjolein Drent; Robert P Baughman
Journal:  Curr Opin Neurol       Date:  2019-06       Impact factor: 5.710

8.  Clinical characteristics and computed tomography findings in Arab patients diagnosed with pulmonary sarcoidosis.

Authors:  Esam H Alhamad; Mohammed O Alanezi; Majdy M Idrees; Mohammad K Chaudhry; Ali M AlShahrani; Arthur Isnani; Shaffi Shaikh
Journal:  Ann Saudi Med       Date:  2009 Nov-Dec       Impact factor: 1.526

Review 9.  Genetic testing in diffuse parenchymal lung disease.

Authors:  Paolo Spagnolo; Fabrizio Luppi; Stefania Cerri; Luca Richeldi
Journal:  Orphanet J Rare Dis       Date:  2012-10-17       Impact factor: 4.123

10.  Cough, sarcoidosis and idiopathic pulmonary fibrosis: raw nerves and bad vibrations.

Authors:  Nicholas Kim Harrison
Journal:  Cough       Date:  2013-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.